Florida SB 860 Died in Committee: What It Means for Compounded Weight-Loss Drugs at Florida Med Spas
Florida SB 860, which would have set documentation rules for compounded weight-loss drugs, died in committee on March 13, 2026. It does not change the underlying federal and state rules a clinic still has to follow.
Key Highlights
- Florida SB 860, a 2026 bill about documentation for compounded weight-loss drugs, died in committee on March 13, 2026.
- A bill dying does not loosen existing rules: federal compounding limits and Florida's pharmacy and medical regulations still apply.
- Florida has no meaningfully enforced corporate-practice bar, so non-physician ownership is generally possible, but a licensed physician still has to direct the clinical program.
- Clinics that sell compounded GLP-1s in Florida should keep their own documentation to the standard the bill described, whether or not it became law.
What Happened to the Bill
Florida SB 860 in the 2026 session concerned documentation for compounded weight-loss drugs. According to the Florida Senate's bill record, it died in committee on March 13, 2026, which means it did not become law and its requirements do not apply.
What Has Not Changed
The failure of one bill does not change the rules that already govern the drugs. Federal limits on compounding apply to all states, and since the national shortages ended FDA has narrowed when a compounded version of an approved drug is appropriate. Florida's pharmacy and medical practice rules continue to govern how prescriptions are written, filled and supervised. Nothing about this episode lets a clinic relax its own documentation.
Florida's Structure Rules
Florida has no meaningfully enforced corporate-practice doctrine, so a non-physician can generally own a med spa outright. A licensed physician still has to direct the clinical side with protocols, standing orders and chart review, and MedGrid builds the same physician-owned PC and management structure in Florida that it builds in strict states, because it is one operating model that does not have to be rebuilt if the law tightens.
What a Good Documentation Standard Looks Like
- Patient-specific prescriptions: A prescriber's written order for each patient, filled by a licensed pharmacy.
- A recorded rationale: A note of why a compounded product is appropriate for this patient, including any documented clinical difference from the approved drug.
- Source records: The pharmacy, lot and strength tied to the patient's chart.
- Honest marketing: No brand-name claims for compounded drugs and no statements that they are the same as an approved drug.
Disclaimer
This article is general educational information, not legal advice. State law changes and depends on the facts of a clinic's structure, so confirm the specifics with health care regulatory counsel in the state before you rely on them.
MedGrid MSO provides management services to independently owned practices; it does not practise medicine and does not direct clinical decisions. Requirements vary by state and by service, and change over time — nothing on this page is legal or medical advice. Talk to us or your own counsel before making a structural decision for your clinic.